Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis

被引:111
作者
Al-Chalabi, Thawab [1 ]
Underhill, James A. [1 ]
Portmann, Bernard C. [1 ]
McFarlane, Ian G. [1 ]
Heneghan, Michael A. [1 ]
机构
[1] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England
关键词
autoimmune hepatitis; gender; cirrhosis; HLA; autoimmune liver disease;
D O I
10.1016/j.jhep.2007.08.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Autoimmune hepatitis (AIH) predominantly affects women. Reasons for this are unclear and few series have assessed long-term outcomes of men with AIH. Methods: To evaluate the clinical course and outcomes of 51 men from a total of 238 consecutive patients with definite AIH at a single centre from 1971 to 2005. The primary outcome measure was death or liver transplantation. Results: Median age at diagnosis was 39 y in men and 49 y in women (p = 0.0589). HLA At, 138 and DR3 allotypes and the HLA A1-B8-DR3 haplotype were more frequently expressed in men (63% vs. 45%, p = 0.049; 74% vs. 38%, p < 0.001; 62% vs. 44%, P = 0.058; and 50% vs. 23%, P = 0.003; respectively). There were no significant differences in clinical manifestations at presentation. Over 96% of patients demonstrated a complete initial response to treatment. A greater number of men experienced at least one relapse (71% vs. 55%, p = 0.0591). However, women were significantly more likely to die or require liver transplantation (Log rank test p = 0.024). Conclusions: Men with AIH appear to have a higher relapse rate and younger age of disease onset which may relate to increased prevalence of HLA AI-B8-DR3. Despite this, men have significantly better long-term survival and outcomes than women. (c) 2007 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:140 / 147
页数:8
相关论文
共 24 条
[1]   International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].
Alvarez, E ;
Berg, PA ;
Bianchi, FB ;
Bianchi, L ;
Burroughs, AK ;
Cancado, EL ;
Chapman, RW ;
Cooksley, WGE ;
Czaja, AJ ;
Desmet, VJ ;
Donaldson, RT ;
Eddleston, ALWF ;
Fainboim, L ;
Heathcote, J ;
Homberg, JC ;
Hoofnagle, JH ;
Kakumu, S ;
Krawitt, EL ;
Mackay, IR ;
MacSween, RNM ;
Maddrey, WC ;
Manns, MP ;
McFarlane, IG ;
zum Büschenfelde, KHM ;
Mieli-Vergani, G ;
Nakanuma, Y ;
Nishioka, M ;
Penner, E ;
Porta, G ;
Portmann, BC ;
Reed, WD ;
Rodes, J ;
Schalm, SW ;
Scheuer, PJ ;
Schrumpf, E ;
Seki, T ;
Toda, G ;
Tsuji, T ;
Tygstrup, N ;
Vergani, D ;
Zeniya, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938
[2]   CHRONIC HEPATITIS - AN UPDATE ON TERMINOLOGY AND REPORTING [J].
BATTS, KP ;
LUDWIG, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (12) :1409-1417
[3]  
Buchel E, 2002, AM J GASTROENTEROL, V97, P3160
[4]   Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis [J].
Czaja, AJ ;
Carpenter, HA .
HEPATOLOGY, 2004, 39 (06) :1631-1638
[5]  
Czaja AJ, 2002, AM J GASTROENTEROL, V97, P2051
[6]   THE EFFECTS OF GENDER AND SEX-HORMONES ON OUTCOME IN RHEUMATOID-ARTHRITIS [J].
DASILVA, JAP ;
HALL, GM .
BAILLIERES CLINICAL RHEUMATOLOGY, 1992, 6 (01) :193-219
[7]   SUSCEPTIBILITY TO AUTOIMMUNE CHRONIC ACTIVE HEPATITIS - HUMAN-LEUKOCYTE ANTIGENS-DR4 AND ANTIGEN-A1-B8-DR3 ARE INDEPENDENT RISK-FACTORS [J].
DONALDSON, PT ;
DOHERTY, DG ;
HAYLLAR, KM ;
MCFARLANE, IG ;
JOHNSON, PJ ;
WILLIAMS, R .
HEPATOLOGY, 1991, 13 (04) :701-706
[8]   In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans [J].
Giltay, EJ ;
Fonk, JCM ;
von Blomberg, BME ;
Drexhage, HA ;
Schalkwijk, C ;
Gooren, LJG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (04) :1648-1657
[9]   Management and outcome of pregnancy in autoimmune hepatitis [J].
Heneghan, MA ;
Norris, SM ;
O'Grady, JG ;
Harrison, PM ;
McFarlane, IG .
GUT, 2001, 48 (01) :97-102
[10]  
Hennes EM, 2005, HEPATOLOGY, V42, p295A